Sushan Luo

28PUBLICATIONS
100CO-AUTHORS
Nanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 27, 2026
When precision medicine meets rigid vaccination: bridging the policy gap for patients on biologics.

|Jun 27, 2026
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study.

|Apr 09, 2026
Gmppb-mutant mice exhibit dystroglycanopathy symptoms that are rescued with GSK3β inhibition or AAV-mediated GMPPB gene replacement.

Ziwei Fu, Tongchao Wang, Chenyang Zhang

|Mar 13, 2026
Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long-Term Real-World Study.

Dingxian He, Chong Yan, Baitong Wang

|Mar 08, 2026
Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study.

Jing Lin, Guoyan Qi, Susan Luo

|Feb 01, 2026
Phospho-MLKL Upregulation in Immune-Mediated Necrotizing Myopathy: Implications for Disease Pathophysiology and Diagnosis.

Mingshi Gao, Nachuan Cheng, Dongyue Yue

Pageof 5

Frequent Collaborators

11 joint publications

Chongbo Zhao

3 joint publications

Zhangyu Zou

3 joint publications

Jie Song

3 joint publications

Dingxian He